Using Vibrational Spectroscopy to Diagnose Fibromyalgia and Related Pain Conditions
Objective tests utilizing Vibrational Spectroscopy for Diagnosis and Severity of Fibromyalgia and Related Pain Syndromes
This study is looking at a new way to help diagnose Fibromyalgia and similar conditions by using special technology to analyze samples from patients, aiming to find clear signs that can help doctors make better decisions and reduce the need for pain medications.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11118918 on NIH RePORTER |
What this research studies
This research investigates the use of vibrational spectroscopy as a diagnostic tool for Fibromyalgia (FM) and other central sensitivity syndromes (CSS). By analyzing biological samples, the study aims to identify specific biomarkers that can accurately diagnose FM, which is often misdiagnosed or overlooked. The approach combines both subjective patient reports and objective spectroscopic data to improve diagnosis and treatment options. This innovative methodology seeks to reduce reliance on opioids by providing clearer diagnostic criteria for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who experience chronic widespread pain and may be diagnosed with Fibromyalgia or other central sensitivity syndromes.
Not a fit: Patients with conditions that do not involve chronic pain or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses of Fibromyalgia and related conditions, ultimately improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in using biomarker identification techniques for diagnosing chronic pain conditions, suggesting that this approach may yield successful outcomes.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Hackshaw, Kevin Victor — University of Texas at Austin
- Study coordinator: Hackshaw, Kevin Victor
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.